10x Genomics, Inc. - Common Stock — Bilan (NASDAQ:TXG)

Afficher le graphique complet Full chart

Financials

Total de l'actif 929.34 M1.02 B1.03 B965.14 M918.64 M1.04 B Total du passif 190.27 M201.26 M223.24 M224.1 M208.5 M245.04 M Total des capitaux propres 739.07 M817.57 M805.74 M741.04 M710.13 M796.33 M Total du passif et des capitaux propres 929.34 M1.02 B1.03 B965.14 M918.64 M1.04 B Dette totale 0————— Dette nette 0—————

10x Genomics, Inc. - Common Stock

10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.

TXG

Financials

10x Genomics, Inc. - Common Stock

Nouvelles

L’action 10x Genomics atteint un plus haut sur 52 semaines à 26,56 $

10x Genomics, Inc. (TXG) Presents at Bank of America Global Healthcare Conference 2026 Transcript

10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript

10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates

Torex Gold T1 2026 : des marges record génèrent 157M$ de flux de trésorerie

Les ETF ARK de Cathie Wood vendent AMD, achètent Shopify et GeneDx

PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?

Hims & Hers Health, Inc. (HIMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?

Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?